Evaxion Biotech Stock (NASDAQ: EVAX) stock price, news, charts, stock research, profile.
Open | $2.79 |
Close | $2.90 |
Volume / Avg. | 8.54K / 46.77K |
Day Range | 2.77 - 2.90 |
52 Wk Range | 2.26 - 13.82 |
Market Cap | $15.10M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 38 |
Short Interest | 1.19% |
Days to Cover | 2.21 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Evaxion Biotech (NASDAQ:EVAX) through any online brokerage.
Other companies in Evaxion Biotech’s space includes: Galecto (NASDAQ:GLTO), Immuron (NASDAQ:IMRN), Monopar Therapeutics (NASDAQ:MNPR), Lumos Pharma (NASDAQ:LUMO) and Can Fite Biofarma (AMEX:CANF).
There is no analysis for Evaxion Biotech.
Evaxion Biotech has a consensus price target of $10.00.
The stock price for Evaxion Biotech (NASDAQ: EVAX) is $2.79 last updated June 28, 2024 at 4:01 PM EDT.
There are no upcoming dividends for Evaxion Biotech.
Evaxion Biotech’s Q2 earnings are confirmed for Thursday, August 15, 2024.
There is no upcoming split for Evaxion Biotech.
Evaxion Biotech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.